Previous Close | 1.2200 |
Open | 1.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 65.00 |
Expire Date | 2025-01-17 |
Day's Range | 1.0000 - 1.2200 |
Contract Range | N/A |
Volume | |
Open Interest | 61 |
Q4 2024 Roivant Sciences Ltd Earnings Call
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.